World’s 1st Nanomedicine CDMO

Through our own R&D experience and manufacturing know-how from internal Nanozyme pipeline, we provide end-to-end CDMO service on early-stage nanomedicine by tailoring client’s needs.

About

OmniParticles

Leading the development of the next-generation therapeutic
modality, we are world’s foremost nanomedicine CDMO service
provider with the most advanced and promising in-house pipeline.

Made-to-Order Nanomedicine Manufacturing

Early-stage

development

+

Mass production

& CMC Regulatory

Custom Synthesis

More

We provide CDMO service on nanomedicine in the early stages of development by tailoring types of nanoparticles, chemical composition, ratio, etc. for specific target diseases and desired therapeutic effect.

CDMO Case Highlights

More

has developed world’s first FDA IND approved anti-inflammatory cerium oxide nanomedicine for acute AND chronic diseases (from critical to degenerative conditions).

OmniParticles

Characterization

More

We assess critical quality attributes of nanomedicines and provide essential insights to ensure their suitability for medical applications.

GMP-compliant Facility

More

Our nanomedicine CDMO services are optimized for early-stage drug development, while our GMP-compliant facility enables in-house DS manufacturing and supports commercial-scale DP production.

Transforming healthcare with innovative nanomedicine solutions

Partnering to pioneer cutting-edge solutions and advanced capabilities in nanomedicine.

About

OmniParticles

Leading the development of the next-generation therapeutic modality, we are world’s foremost nanomedicine CDMO service provider with the most advanced and promising in-house pipeline.

Made-to-Order Nanomedicine Manufacturing​

Custom Synthesis

We provide CDMO service on nanomedicine in the early stages of development by tailoring types of nanoparticles, chemical composition, ratio, etc. for specific target diseases and desired therapeutic effect.

CDMO Case Highlights​

has developed world’s first FDA IND approved anti-inflammatory cerium oxide nanomedicine for acute AND chronic diseases (from critical to degenerative conditions).

OmniParticles

Characterization

We assess critical quality attributes of nanomedicines and provide essential insights to ensure their suitability for medical applications.

GMP-compliant Facility

Our nanomedicine CDMO services are optimized for early-stage drug development​, while our GMP-compliant facility enables in-house DS manufacturing and supports commercial-scale DP production.

Leading the development of the next-generation therapeutic
modality, we are world’s foremost nanomedicine CDMO service
provider with the most advanced and promising in-house pipeline.

Made-to-Order Nanomedicine Manufacturing

CDMO Case Highlights

Our nanomedicine CDMO services are optimized for early-stage drug development, while our GMP-compliant facility enables in-house DS manufacturing and supports commercial-scale DP production.